Wednesday, January 3, 2018

4 Things Pharmacists Should Know About the Shingrix Vaccine

Pharmacy Times-1 hour ago
Shingrix (Zoster Vaccine Recombinant, Adjuvanted) was approved in October 2017 for adults 50 and older for the prevention of shingles, a viral infection that causes a painful rash that generally develops on 1 side of the body, usually the face or torso. The risk of shingles and post-herpetic neuralgia (PHN) increases with ...
Post a Comment